Allarity Therapeutics, Inc. SEC filings ALLR
Allarity Therapeutics, Inc. has 403 filings in SEC EDGAR's recent list, going back to May 27, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 30, 2026 | — |
| 424B3 | Prospectus | Apr 27, 2026 | — |
| S-3/A | Amendment no. 1 to form s-3 | Apr 24, 2026 | — |
| S-3 | Shelf registration | Feb 12, 2026 | — |
| 424B5 | Prospectus supplement | Jan 29, 2026 | — |
| S-3 | Shelf registration | Dec 3, 2025 | — |
| 424B3 | Prospectus | Sep 30, 2025 | — |
| S-3 | Shelf registration | Sep 25, 2025 | — |
| 424B5 | Prospectus supplement | Sep 9, 2024 | — |
| S-3 | Shelf registration | Aug 30, 2024 | — |
| 424B5 | Prospectus supplement | May 17, 2024 | — |
| 424B5 | Prospectus supplement | May 15, 2024 | — |
| 424B5 | Prospectus supplement | May 9, 2024 | — |
| 424B5 | Prospectus supplement | May 6, 2024 | — |
| 424B5 | Prospectus supplement | May 2, 2024 | — |
| 424B5 | Prospectus supplement | May 2, 2024 | — |
| 424B5 | Prospectus supplement | May 2, 2024 | — |
| S-1/A | Amended registration statement | Apr 17, 2024 | — |
| 424B5 | Prospectus supplement | Apr 15, 2024 | — |
| 424B5 | Prospectus supplement | Apr 12, 2024 | — |
| 424B5 | Prospectus supplement | Apr 11, 2024 | — |
| 424B5 | Prospectus supplement | Apr 9, 2024 | — |
| S-1/A | Amended registration statement | Apr 8, 2024 | — |
| S-8 | Employee stock plan registration | Mar 25, 2024 | — |
| 424B5 | Prospectus supplement | Mar 20, 2024 | — |
| S-1/A | Amended registration statement | Dec 15, 2023 | — |
| S-1/A | Amended registration statement | Dec 6, 2023 | — |
| S-1/A | Amended registration statement | Dec 5, 2023 | — |
| S-3 | Shelf registration | Nov 2, 2023 | — |
| S-1 | Registration statement | Oct 30, 2023 | — |
| 424B3 | Prospectus | Oct 23, 2023 | — |
| S-3/A | Amendment no. 1 to form s-3 | Oct 17, 2023 | — |
| S-3 | Shelf registration | Oct 10, 2023 | — |
| 424B4 | Prospectus | Jul 7, 2023 | — |
| S-1/A | Amended registration statement | Jun 30, 2023 | — |
| S-1 | Registration statement | Jun 7, 2023 | — |
| 424B4 | Prospectus | Apr 20, 2023 | — |
| S-1/A | Amended registration statement | Apr 17, 2023 | — |
| S-1/A | Amended registration statement | Apr 4, 2023 | — |
| S-1/A | Amended registration statement | Mar 28, 2023 | — |
| S-1 | Registration statement | Mar 14, 2023 | — |
| 424B3 | Prospectus | Jan 23, 2023 | — |
| 424B3 | Prospectus | Dec 23, 2022 | — |
| 424B3 | Prospectus | Dec 21, 2022 | — |
| 424B3 | Prospectus | Dec 12, 2022 | — |
| 424B3 | Prospectus | Dec 2, 2022 | — |
| 424B3 | Prospectus | Nov 15, 2022 | — |
| 424B3 | Prospectus | Nov 8, 2022 | — |
| 424B3 | Prospectus | Oct 7, 2022 | — |
| 424B3 | Prospectus | Sep 30, 2022 | — |
| 424B3 | Prospectus | Sep 26, 2022 | — |
| 424B3 | Prospectus | Aug 22, 2022 | — |
| 424B3 | Prospectus | Aug 12, 2022 | — |
| 424B3 | Prospectus | Aug 2, 2022 | — |
| 424B3 | Prospectus | Jul 11, 2022 | — |
| 424B3 | Prospectus | Jun 30, 2022 | — |
| 424B3 | Prospectus | Jun 7, 2022 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Jun 3, 2022 | — |
| 424B3 | Prospectus | Apr 1, 2022 | — |
| 424B3 | Prospectus | Dec 21, 2021 | — |
| S-1/A | Amended registration statement | Dec 16, 2021 | — |
| S-1/A | Amended registration statement | Dec 15, 2021 | — |
| S-1/A | Amended registration statement | Dec 6, 2021 | — |
| 424B3 | Prospectus | Nov 5, 2021 | — |
| S-4/A | Registration statement | Nov 4, 2021 | — |
| S-4/A | Registration statement | Nov 2, 2021 | — |
| S-4/A | Amendment no. 3 to form s-4 | Oct 20, 2021 | — |
| S-4/A | Registration statement | Oct 20, 2021 | — |
| S-4/A | Registration statement | Oct 20, 2021 | — |
| S-4/A | Registration statement | Oct 18, 2021 | — |
| S-1/A | Amended registration statement | Oct 12, 2021 | — |
| S-4/A | Registration statement | Sep 29, 2021 | — |
| S-1 | Registration statement | Sep 13, 2021 | — |
| S-4 | Registration for a merger or exchange | Aug 20, 2021 | — |
Showing 74 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALLR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1860657
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.